AI in pathology market to reach USD 89.71M by 2032

The global AI in pathology market size and share is predicted to grow from USD 21.73 Million in 2022 to USD 89.71 Million in 2032. It is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 15.3% from 2023 to 2032, according to the latest report by Polaris Market Research.

Pathology is known as the analysis of ailments, and it lies at the intersection of science and medicine. It is a part of medicine that mainly studies the origins, nature, and causes of illnesses. Additionally, pathology is a crucial part of the diagnostic pathways that have been set up for a variety of disease indications, most notably the identification of cancer.

Also, the need for effective healthcare facilities and labs to deliver high-quality patient care is being driven by the growing global population. Lower healthcare staff is promoting the use of AI in pathology. The AI in pathology market demand is icreasing as pathologists are becoming more aware of the advantages of technology due to the growing body of research on its application, particularly in the areas of artificial intelligence and machine learning.

Major market players of AI in pathology

• 4D Path
• Aiforia Technologies
• Aiosyn
• Akoya Biosciences
• deepPath
• Deep Bio
• DoMore Diagnostics AS
• F. Hoffmann-La Roche
• Hologic
• Ibex Medical Analytics
• Indica Labs
• Konfoong Biotech International
• Koninklijke Philips N.V.
• Lumea
• Mindpeak

Regional insights
Asia Pacific: The AI in pathology market in Asia Pacific is expanding as a result of the expanding application of AI in healthcare sectors in developing nations like as China and India. The healthcare AI industry in India is anticipated to expand at a 40% CAGR by 2025, according to NASSCOM. This shows how artificial intelligence is becoming more and more popular in the healthcare sector. Because AI can do repetitive jobs rapidly and save pathologists time, this could lead to even more applications of AI in pathology.

North America: Because telemedicine is becoming more and more popular, the North American region is anticipated to develop at the fastest rate throughout the forecast period, with a solid CAGR. Because of Covid-19’s strict lockdown requirements, telemedicine has become more popular than in-person sessions. The US Department of Health and Human Services reports that Medicare enrollees have used telemedicine more frequently in the US since the outbreak. Polaris Market Research